Gallstone disease future or investigational therapies: Difference between revisions
Ochuko Ajari (talk | contribs) No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gallstone disease}} | {{Gallstone disease}} | ||
{{CMG}}; {{AE}} | |||
{{PleaseHelp}} | |||
==Overview== | |||
==Future or Investigational Therapies== | |||
==References== | ==References== | ||
Line 10: | Line 16: | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 13:42, 18 July 2016
Gallstone disease Microchapters |
Diagnosis |
---|
Treatment |
Surgery |
Case Studies |
Gallstone disease future or investigational therapies On the Web |
American Roentgen Ray Society Images of Gallstone disease future or investigational therapies |
FDA on Gallstone disease future or investigational therapies |
CDC on Gallstone disease future or investigational therapies |
Gallstone disease future or investigational therapies in the news |
Blogs on Gallstone disease future or investigational therapies |
Risk calculators and risk factors for Gallstone disease future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.